Maruti Suzuki, the largest car manufacturer in India, announced a first net loss in 17 years in the second quarter of 2020, data published by the company show.
The economy of Hong Kong contracted 9% in the second quarter of 2020, compared to the same period the prior year, official data show.
Spotify Technology reported on Wednesday it had gained 138M paid subscribers in the Q2, as music streaming service's demand had rebounded after the coronavirus-related weakness.
On Wednesday, General Dynamics, the defence contractor, reported a 22.5% drop in its Q2 profit to $625M, or $2.18 for a share, tumbled by weaker sales in the company's IT and aerospace units.
US oil refiners are expected to post their worst Q2 results since 2010, as the production outran the demand during the coronavirus crisis, hitting auto and air travel sectors.
Tesla's CEO Elon Musk stated that the electric carmaker was open to supply batteries and powertrains to other companies, seeking to accelerate sustainable energy, not hurting the competition.
The largest tech show CES conducted in Las Vegas every January will be held online only next year amid the coronavirus pandemic concerns, its organiser Consumer Technology Association announced.
Shares of the McDonald's Japanese affiliate plunged 10% on Wednesday, following the US fast-food company's announcement about a stake cut in the publicly listed overseas division amid intention to boost its finances.
South Korea has launched an investigation into the alleged safety issues with cars produced by Tesla, the major competitor to Hyundai Motor in South Korea's EV market.
France's largest telecoms company Orange and Alphabet's Google announced their strategic partnership on providing data, cloud computing and Ai services to the European market.
Ctrip, the Chinese online travel titan, has entered talks with investors over funding the company's delisting from Nasdaq due to growing tensions between China and the United States.
EBay topped Wall Street's estimates for its Q2 revenue results and raised its annual outlook, driven by a surge in the e-commerce company's online shopping during the coronavirus-led lockdowns.
L Brands is planning 850 layoffs, which are 15% of the company's corporate workforce, while also anticipating a smaller-than-expected fall in its Q2 sales, and sending shares up 17% on the news.
Amgen reported a 6% growth in its Q2 revenue on higher sales of its newer drugs, with the results being largely in line with the forecasts, while shares fell about 2% in the extended trading.
Starbucks said its global business was recovering steadily as the company reopened most of the stores after easing of the coronavirus-led restrictions.
Italy's parliament endorsed the request of the Prime Minister to prolong the state of emergency until October 15 to prevent the likelihood of a returning spread of the virus.
The British spaceflight company, founded by Sir Richard Branson and Burt Rutan, revealed the interior of its space aircraft on Tuesday, a ticket will cost $250K per passenger.
The US consumer confidence stepped down more than anticipated in July due to the surge in coronavirus cases, consumers are pessimistic about the prospects over the subsequent half of the year.
On Wednesday, the US lawmakers will question Apple Inc's CEO Tim Cook regarding the possibly unfair company's practices on the App Store.
China's Ctrip was in talks with investors over financing its delisting from Nasdaq due to rising US-China tensions and the coronavirus-driven hit to business.
Spain's utility Endesa SA reported a 45% increase in H1 net profit to €1.13B amid cost savings after getting a collective-bargaining deal with staff.
Tesla's rival Lucid Motors is building a new Air luxury EV equipped with a semi-automated assistance system, seeking to launch it in early 2021, the carmaker stated on Tuesday.
McDonald's reported on Tuesday its global same-store sales dropped more than expected, while its profit also missed the forecasts due to restaurant shutdowns triggered by the coronavirus pandemic.
On Tuesday, Pfizer Inc topped analysts' forecasts for its Q2 profit and raised its annual outlook, on rising demand for the company's blood thinner Eliquis and cancer drug Ibrance.